Homologation of glutamic acid chain together with conformational constraint is a commonly used strategy to achieve selectivity towards different types of glutamate receptors. In the present work, starting from two potent and selective unnatural amino acids previously developed by us, we investigated the effects on the activity/selectivity profile produced by a further increase in the distance between the amino acidic moiety and the distal carboxylate group. Interestingly, the insertion of an aromatic ring as a spacer produced a low micromolar affinity NMDA ligand that might represent a lead for the development of a new class of NMDA antagonists.

Synthesis and pharmacological evaluation of conformationally constrained glutamic acid higher homologues / L. Tamborini, G. Cullia, B. Nielsen, C. De Micheli, P. Conti, A. Pinto. - In: BIOORGANIC & MEDICINAL CHEMISTRY. - ISSN 0968-0896. - 24:22(2016 Nov 15), pp. 5741-5747. [10.1016/j.bmc.2016.09.029]

Synthesis and pharmacological evaluation of conformationally constrained glutamic acid higher homologues

L. Tamborini
Primo
;
G. Cullia
Secondo
;
C. De Micheli;P. Conti
Penultimo
;
A. Pinto
2016

Abstract

Homologation of glutamic acid chain together with conformational constraint is a commonly used strategy to achieve selectivity towards different types of glutamate receptors. In the present work, starting from two potent and selective unnatural amino acids previously developed by us, we investigated the effects on the activity/selectivity profile produced by a further increase in the distance between the amino acidic moiety and the distal carboxylate group. Interestingly, the insertion of an aromatic ring as a spacer produced a low micromolar affinity NMDA ligand that might represent a lead for the development of a new class of NMDA antagonists.
1,3-dipolar cycloaddition; amino acid; l-glutamic acid; n-methyl-d-aspartate receptor; δ2-isoxazoline; biochemistry; molecular medicine; molecular biology; 3003; drug discovery3003 pharmaceutical science; clinical biochemistry; organic chemistry
Settore CHIM/08 - Chimica Farmaceutica
15-nov-2016
Article (author)
File in questo prodotto:
File Dimensione Formato  
Tamborini_BioorganicMedChemistry_Synthesis_2016.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 576.97 kB
Formato Adobe PDF
576.97 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/454744
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 1
social impact